MariMed Inc.
MRMD
$0.08
$0.00-1.27%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 6.93% | 0.42% | -2.05% | 0.06% | 0.13% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.93% | 0.42% | -2.05% | 0.06% | 0.13% |
| Cost of Revenue | 18.46% | 2.47% | 0.21% | 6.32% | 21.83% |
| Gross Profit | -17.02% | -2.50% | -5.19% | -8.10% | -26.92% |
| SG&A Expenses | 6.86% | -2.97% | -5.45% | 10.51% | -5.92% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.44% | 0.36% | -2.05% | 8.00% | 10.51% |
| Operating Income | -235.48% | 1.63% | -1.99% | -135.11% | -153.76% |
| Income Before Tax | -120.99% | 45.67% | 25.10% | -750.50% | 65.57% |
| Income Tax Expenses | -154.30% | 321.22% | -20.21% | 67.51% | 872.10% |
| Earnings from Continuing Operations | 43.84% | -197.07% | 22.51% | -319.50% | 18.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 433.33% | 56.25% | 108.33% | -433.33% | 90.00% |
| Net Income | 43.98% | -193.04% | 23.14% | -320.03% | 18.70% |
| EBIT | -235.48% | 1.63% | -1.99% | -135.11% | -153.76% |
| EBITDA | -190.19% | 3.00% | 5.82% | -54.34% | -65.66% |
| EPS Basic | 46.08% | -188.46% | 25.00% | -308.57% | 19.63% |
| Normalized Basic EPS | -101.92% | -- | 0.00% | -510.00% | -1,833.33% |
| EPS Diluted | 46.08% | -284.62% | 25.00% | -308.57% | 19.63% |
| Normalized Diluted EPS | -101.92% | -- | 0.00% | -510.00% | -1,833.33% |
| Average Basic Shares Outstanding | 3.69% | 3.16% | 2.74% | 1.96% | 1.39% |
| Average Diluted Shares Outstanding | 3.69% | 3.16% | 2.74% | 1.96% | 1.39% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |